Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06444269Phase 2Recruiting
Phase 2, open-label trial in breast cancer (2 cohorts), sponsored by UT Southwestern Medical Center. Primary endpoint: Single fraction pre-operative radiation at 4 years. Started Oct 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06444269.